查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1449296

全球兽用AP（活性药物成分）市场市场：份额、规模、趋势、行业分析报告- 按服务类型、按合成类型、按动物类型、按治疗类别、按地区、细分市场预测，2024 -2032 年

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Service Type ; By Synthesis Type; By Animal Type; By Therapeutic Category; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

到2032年，全球兽用API（活性药物成分）製造市场规模预计将达到146.3亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

兽用原料药是兽药的重要组成部分。 这些成分负责产生所需的治疗效果，并在批准用于商业用途之前经过严格的测试和研究。 随着动物保健解决方案的需求不断增加，高品质兽用原料药市场也蓬勃发展。 由于多种因素的影响，该市场预计将成长，包括兽药研发、外包、设施扩建和动物保健支出增加的投资。

动物 API 市场是由外包 API 製造的营运和成本效益优势所驱动的。 动物保健公司正在积极寻求优化营运和降低成本的方法。 透过将兽用原料药生产外包给专业製造商，製药公司可以专注于其核心优势，例如研发、行销和分销。 在人们日益认识到动物健康和福利的重要性的推动下，这一趋势导致了动物 API 市场的显着扩张。

由于跨境感染和人畜共通传染病的日益流行，兽用 AP 市场正在经历显着增长。 这些疾病对动物和人类都构成重大风险，并且可以迅速跨境传播，对公共卫生、全球贸易和动物福利构成威胁。 兽用原料药的使用对于控制和预防这些疾病的传播变得极为重要。 兽药在治疗受影响的动物、制定有效的治疗策略以及减轻症状的严重程度以帮助受影响的动物康復方面发挥着至关重要的作用。 动物原料药製造业高度多样化，满足不同动物物种的多样化健康需求。 它由众多公司组成，从大型跨国製药公司到中型公司。

动物 API 製造市场报告重点

该市场由自有製造部门主导，主要是因为存在许多大型兽药製造商，他们建立了自己的原料药生产设施。 这项策略措施确保了供应链不间断，并严格控制产品品质。

在评估期间，动物 API 製造市场预计生物 API 产业将显着成长。 这种增长是由动物保健领域对先进生物製品和疫苗的需求不断增长所推动的。

2023年，抗感染产业是全球兽用原料药製造市场的最大贡献者。 这是因为对治疗动物细菌、真菌和病毒感染的抗生素和其他抗菌剂的需求量很大。

2023年的全球市场以北美地区为主，这主要是由于美国和加拿大等国家已经建立了动物保健产业。 这些产业的存在导致对动物原料药的高需求，使北美成为动物原料药的最大市场。

目录

第1章简介

第 2 章执行摘要

第3章研究方法

第 4 章全球动物 API 製造市场洞察

  • 动物 API 製造 - 产业概况
  • 动物 API 製造 - 市场动态
    • 推动者和机会
    • 抑制因素和挑战
  • 杵分析
  • 动物原料药製造业的趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球动物 API 製造市场：依服务类型

  • 主要发现
  • 简介
  • 内部
  • 合约工作外包

第 6 章全球动物 API 製造市场：依合成类型

  • 主要发现
  • 简介
  • 生物原料药
  • 基于化学的 API
  • HPAPI

第 7 章全球动物原料药製造市场：依治疗类别

  • 主要发现
  • 简介
  • 驱虫药
  • 抗感染药物
  • 非类固醇抗发炎药
  • 其他

第 8 章全球动物 API 製造市场：依动物类型

  • 主要发现
  • 简介
  • 生产动物
  • 伴侣动物

第 9 章按地区划分的全球动物 API 製造市场

  • 主要发现
  • 简介
    • 动物 API 製造市场评估：按地区（2019-2032 年）
  • 动物 API 製造市场 - 北美
    • 依服务类型
    • 依动物类型
    • 依成分型
    • 依治疗类别
    • 美国
    • 加拿大
  • 动物 API 製造市场 - 欧洲
    • 依服务类型
    • 依动物类型
    • 依成分型
    • 依治疗类别
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 动物 API 製造市场 - 亚太地区
    • 依服务类型
    • 依动物类型
    • 依成分型
    • 依治疗类别
    • 中国
    • 印度
    • 日本
    • 马来西亚
    • 印尼
    • 韩国
  • 动物 API 製造市场 - 中东和非洲
    • 依服务类型
    • 依动物类型
    • 依成分型
    • 依治疗类别
    • 沙乌地阿拉伯
    • 南非
    • 以色列
    • 阿联酋
  • 动物 API 製造市场 - 拉丁美洲
    • 依服务类型
    • 依动物类型
    • 依成分型
    • 依治疗类别
    • 墨西哥
    • 巴西
    • 阿根廷

第10章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第11章公司简介

  • Alivira Animal Health Ltd.
  • Chempro Pharma Pvt. Ltd
  • Elanco
  • Excel Industries Ltd.
  • MENADIONA
  • Ofichem Group
  • Qilu Animal Health Products Co., Ltd.
  • Siflon Drugs
  • SUANFARMA
  • Vetpharma
  • Zoetis
Product Code: PM4540

The global Veterinary Active Pharmaceutical Ingredients Manufacturing market size is expected to reach USD 14.63 Billion by 2032, according to a new study by Polaris Market Research. The report "Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Service Type (In House, Contract Outsourcing); By Synthesis Type; By Animal Type; By Therapeutic Category; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Veterinary active pharmaceutical ingredients (APIs) are essential components of animal medicines. These ingredients are responsible for producing the desired therapeutic effects and undergo rigorous testing and research before they are approved for commercial use. As the demand for animal healthcare solutions continues to increase, the market for high-quality veterinary APIs is also growing rapidly. The market is anticipated to grow owing to numerous factors such as research & development of veterinary products, increasing investment in outsourcing, facility expansion, and expenditure on animal health.

The veterinary active pharmaceutical ingredient (API) market has been driven by the operational and cost-effectiveness benefits of outsourcing the manufacturing of APIs. Animal health companies are actively seeking ways to optimize their operations and reduce costs. By outsourcing the production of veterinary APIs to specialized manufacturers, pharmaceutical companies can focus on their core strengths, including research, development, marketing, and distribution. This trend has led to a significant expansion in the veterinary API market, driven by a growing awareness of the importance of animal health and welfare.

The market for veterinary active pharmaceutical ingredients (APIs) is witnessing significant growth owing to the rising prevalence of transboundary and zoonotic diseases. These diseases pose a significant risk to both animal and human populations and can spread rapidly across borders, posing a threat to public health, global trade, and animal welfare. The use of veterinary APIs has become crucial in controlling and preventing the spread of these diseases. They play a pivotal role in treating diseased animals, developing effective treatment strategies, and reducing the severity of symptoms, which aids in the recovery of affected animals. The veterinary API manufacturing sector is highly diverse and caters to the varied health needs of different animal species. It comprises a broad spectrum of companies ranging from large multinational pharmaceutical corporations to mid-sized enterprises.

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Highlights

The market is dominated by the in-house segment, mainly due to the presence of numerous leading animal health companies that have set up their own API manufacturing facilities. This strategic move has helped them ensure an uninterrupted supply chain and maintain strict control over the quality of their products.

The veterinary API manufacturing market is projected to witness substantial growth in the biological API segment in the assessment period. This growth can be attributed to the rising need for advanced biologics and vaccines for animal healthcare.

In 2023, the global market for manufacturing veterinary active pharmaceutical ingredients (API) had the anti-infective segment as the largest contributor. This was due to the significant demand for antibiotics and other anti-microbial agents to treat bacterial, fungal, and viral infections in animals.

The global market in 2023 was dominated by the North American region, primarily due to the well-established animal healthcare industries in countries such as the United States and Canada. The presence of these industries has resulted in a high demand for veterinary APIs, making North America the largest market for veterinary APIs.

The global key market players include Alivira Animal Health Ltd., Chempro Pharma Pvt. Ltd., Elanco, Excel Industries Ltd., MENADIONA, Ofichem Group, Qilu Animal Health Products Co., Ltd., Siflon Drugs, SUANFARMA, Vetpharma, Zoetis, and among others.

Polaris Market Research has segmented the Veterinary Active Pharmaceutical Ingredients Manufacturing market report based on service type, synthesis type, animal type, therapeutic category, and region:

Veterinary Active Pharmaceutical Ingredients Manufacturing, Service Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • In House
  • Contract Outsourcing
  • Contract Development
  • Preclinical Development
  • Clinical Development
  • Contract Manufacturing

Veterinary Active Pharmaceutical Ingredients Manufacturing, Synthesis Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Biological API
  • Chemical-based API
  • HPAPI

Veterinary Active Pharmaceutical Ingredients Manufacturing, Animal Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Production Animals
  • Companion Animals

Veterinary Active Pharmaceutical Ingredients Manufacturing, Therapeutic Category Outlook (Revenue - USD Billion, 2019 - 2032)

  • Antiparasitic
  • Anti-infectives
  • NSAIDs
  • Others

Veterinary Active Pharmaceutical Ingredients Manufacturing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Insights

  • 4.1. Veterinary Active Pharmaceutical Ingredients Manufacturing - Industry Snapshot
  • 4.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing prevalence of transboundary and zoonotic diseases fuels veterinary active pharmaceutical ingredients manufacturing market growth
      • 4.2.1.2. The cost-effectiveness and operational advantages of outsourcing API manufacturing drives market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The high cost of veterinary diagnostic and treatment hampers veterinary active pharmaceutical ingredients manufacturing market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • 5.3. In-house
    • 5.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by In-house, by Region, 2019-2032 (USD Billion)
  • 5.4. Contract Outsourcing
    • 5.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Outsourcing, by Region, 2019-2032 (USD Billion)
    • 5.4.2. Contract Development
      • 5.4.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Development, by Region, 2019-2032 (USD Billion)
      • 5.4.2.2 Preclinical Development
      • 5.4.2.21. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Preclinical Development, by Region, 2019-2032 (USD Billion)
      • 5.4.2.3 Clinical Development
      • 5.4.2.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Clinical Development, by Region, 2019-2032 (USD Billion)
    • 5.4.3. Contract Manufacturing
      • 5.4.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Manufacturing, by Region, 2019-2032 (USD Billion)

6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • 6.3. Biological API
    • 6.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Biological API, by Region, 2019-2032 (USD Billion)
  • 6.4. Chemical-based API
    • 6.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Chemical-based API, by Region, 2019-2032 (USD Billion)
  • 6.5. HPAPI
    • 6.5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by HPAPI, by Region, 2019-2032 (USD Billion)

7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • 7.3. Antiparasitic
    • 7.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Antiparasitic, by Region, 2019-2032 (USD Billion)
  • 7.4. Anti-infectives
    • 7.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Anti-infectives, by Region, 2019-2032 (USD Billion)
  • 7.5. NSAIDs
    • 7.5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by NSAIDs, by Region, 2019-2032 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • 8.3. Production Animals
    • 8.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Production Animals, by Region, 2019-2032 (USD Billion)
  • 8.4. Companion Animals
    • 8.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Companion Animals, by Region, 2019-2032 (USD Billion)

9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - North America
    • 9.3.1. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
    • 9.3.2. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
    • 9.3.3. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
    • 9.3.4. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.3.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - U.S.
      • 9.3.5.1. U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.3.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Canada
      • 9.3.6.1. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • 9.4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Europe
    • 9.4.1. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - UK
      • 9.4.5.1. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - France
      • 9.4.6.1. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Germany
      • 9.4.7.1. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Italy
      • 9.4.8.1. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Spain
      • 9.4.9.1. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Netherlands
      • 9.4.10.1. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.11. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Russia
      • 9.4.11.1. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • 9.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - China
      • 9.5.5.1. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - India
      • 9.5.6.1. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Japan
      • 9.5.7.1. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Malaysia
      • 9.5.8.1. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Indonesia
      • 9.5.9.1. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - South Korea
      • 9.5.10.1. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • 9.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.6.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.6.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - South Africa
      • 9.6.6.1. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.6.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Israel
      • 9.6.7.1. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.6.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - UAE
      • 9.6.8.1. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • 9.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Latin America
    • 9.7.1. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.7.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Mexico
      • 9.7.5.1. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.7.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Brazil
      • 9.7.6.1. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.7.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Argentina
      • 9.7.7.1. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Alivira Animal Health Ltd.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Chempro Pharma Pvt. Ltd
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Elanco
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Excel Industries Ltd.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. MENADIONA
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Ofichem Group
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Qilu Animal Health Products Co., Ltd.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Siflon Drugs
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. SUANFARMA
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Vetpharma
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Zoetis
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development

List of Tables

  • Table 1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, by Region, 2019-2032 (USD Billion)
  • Table 5 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 7 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 8 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 9 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 11 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 12 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 13 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 14 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 15 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 16 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 17 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 18 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 19 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 20 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 21 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 22 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 23 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 25 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 26 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 27 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 28 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 29 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 30 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 31 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 32 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 33 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 34 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 35 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 36 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 37 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 42 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 43 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 44 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 45 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 46 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 47 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 48 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 49 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 54 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 55 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 56 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 57 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 58 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 59 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 60 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 61 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 62 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 63 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 64 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 65 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 74 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 75 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 76 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 77 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 78 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 79 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 80 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 81 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 83 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 84 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 85 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 86 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 87 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 88 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 89 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 90 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 91 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 92 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 93 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 98 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 99 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 100 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 101 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 106 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 107 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 108 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 109 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 110 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 111 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 112 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 113 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Animal Type
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Service Type
  • Figure 7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Animal Type
  • Figure 9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Synthesis Type
  • Figure 11. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Therapeutic Category
  • Figure 13. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2021 & 2030 (USD Billion)